Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences Read more about Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences Iovance Biotherapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021 Read more about Iovance Biotherapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021 Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial Officer Read more about Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial Officer Iovance Biotherapeutics to Present at Upcoming Conferences in December Read more about Iovance Biotherapeutics to Present at Upcoming Conferences in December Iovance Biotherapeutics Presents Clinical Data in Head and Neck Cancer at Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting Read more about Iovance Biotherapeutics Presents Clinical Data in Head and Neck Cancer at Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2020 Financial Results and Corporate Updates Read more about Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2020 Financial Results and Corporate Updates Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020 Read more about Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020 Iovance Biotherapeutics to Present at Upcoming Conferences in November Read more about Iovance Biotherapeutics to Present at Upcoming Conferences in November Iovance Biotherapeutics to Present Clinical Data in Head and Neck Cancer at Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting Read more about Iovance Biotherapeutics to Present Clinical Data in Head and Neck Cancer at Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting Iovance Biotherapeutics to Present at Upcoming October Conferences Read more about Iovance Biotherapeutics to Present at Upcoming October Conferences Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last » Subscribe to
Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences Read more about Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences
Iovance Biotherapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021 Read more about Iovance Biotherapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021
Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial Officer Read more about Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial Officer
Iovance Biotherapeutics to Present at Upcoming Conferences in December Read more about Iovance Biotherapeutics to Present at Upcoming Conferences in December
Iovance Biotherapeutics Presents Clinical Data in Head and Neck Cancer at Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting Read more about Iovance Biotherapeutics Presents Clinical Data in Head and Neck Cancer at Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting
Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2020 Financial Results and Corporate Updates Read more about Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2020 Financial Results and Corporate Updates
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020 Read more about Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020
Iovance Biotherapeutics to Present at Upcoming Conferences in November Read more about Iovance Biotherapeutics to Present at Upcoming Conferences in November
Iovance Biotherapeutics to Present Clinical Data in Head and Neck Cancer at Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting Read more about Iovance Biotherapeutics to Present Clinical Data in Head and Neck Cancer at Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting
Iovance Biotherapeutics to Present at Upcoming October Conferences Read more about Iovance Biotherapeutics to Present at Upcoming October Conferences
